Fraud, Waste, and Abuse

Paul, Reid
March 2011
Pharmaceutical Representative;Mar2011, Vol. 41 Issue 3, p5
The article discusses issues surrounding the pharmaceutical industry in the U.S. It highlights the effort of legislators to look for new ways to boost revenue such as user fees and court settlement in line with a 2.7 trillion dollar budget proposal and a projected debt of 1.1 trillion dollars. Alleged reports on fraud and abuse cases committed by pharmaceutical and device manufacturers in the country are mentioned.


Related Articles

  • CONSUMER MARKETING: Update.  // Medical Marketing & Media;Jan2012, Vol. 47 Issue 1, p23 

    The article offers news briefs related to healthcare and pharmaceutical industry in the U.S., mentioning the advertising campaign launch by Presbyterian Hospital, the results of a survey on attitudes towards advertising and the survey that pushes the therapeutic substitution of generics drugs.

  • Cracking the fraudulent-data code. Weinstein, Deborah // Medical Marketing & Media;Nov2012, Vol. 47 Issue 11, p24 

    The article focuses on a study published by the "Proceedings of the National Academy of Science" which reveals that 43.3% of retracted articles in the U.S. were pulled over false and fabricated information or suspicion of fraud.

  • BioWorld Asia ... Bonus Addition Today.  // BioWorld Today;2/12/2014, Vol. 25 Issue 29, p1 

    The article reports on the launch of the periodical "BioWorld Asia" which aims to provide pharmaceutical executives with business, financial, and regulatory developments affecting the bio-pharmaceutical industry to help them make better short- and long-term business decisions.

  • PE Investments Soar. Kulkarni, Narayan // BioSpectrum;Oct2012, Vol. 10 Issue 10, p42 

    The article focuses on the growth of private equity (PE) investments in the life sciences sector in India. It states that the sector has generated 137 percent growth in 2012. It says that the health and life sciences industry generated investments worth of $268 million until October 2012 against...

  • MEDICAL DEVICES. STANLEY, LYNN // Modern Metals;Oct2015, Vol. 71 Issue 9, p50 

    The article reports that medical device makers in the U.S,. continue to grow despite challenges within the healthcare industry as of 2015. Topics include the medical device market of the U.S. expected to reach 110 billion dollars in annual revenues by 2016 as per SelectUSA, an agency of the U.S....

  • Pharmacies & Drug Stores Industry (NAICS 44611).  // United States Pharmacies & Drug Stores Industry Capital & Expens;2012, preceding p1 

    This publication presents a market report on the U.S. pharmacies and drug stores industry. It contains a users' guide, industry definition and terms, and related industries. Several charts are also presented that show industry figures in 2011, 2012 and 2013, including estimated number of...

  • Better adherence would be boon for pharmaceutical industry.  // Chain Drug Review;1/7/2013, Vol. 35 Issue 1, p70 

    The article informs about the report which provides insights into the significant revenue loss to pharmaceutical firms in the U.S. as a result of medication nonadherence.

  • Weekly Stock Performance (as of December 5, 2014).  // MondayMorning;12/8/2014, Vol. 22 Issue 45, p1 

    A chart showing the weekly stock performance of pharmaceutical and medical devices companies in the U.S. as of December 5, 2014, is presented.

  • UNITED STATES PHARMACEUTICALS.  // Acquisdata Industry SnapShot: United States - Pharmaceuticals;9/11/2015, Issue 3397, preceding p1 

    An industry report of the pharmaceuticals industry in the U.S. as of September 11, 2015 is presented from publisher Acquisdata Pty. Ltd., with topics including the low default risk of Eli Lilly, the decline in medical device stocks, and the overviews of the industry's companies.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics